The AZ Vaccine – Clot risks and questions about herd immunity – Lecture

   Rated 0 / 5 stars

Save

CPD for this activity

Educational Activities (EA)

0 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0 mins

Educational Activities (EA)
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0 mins

Reviewing Performance (RP)
These are activities that require reflection on feedback about your work.

MO
0 mins

Measuring Outcomes (MO)
These are activities that use your work data to ensure quality results.

Listen to the episode

Description

Dr Michelle Ananda-Rajah, will walk us through the data, help us understand our role as GPs and look at what can be done to get our patients and the country back on track to long term protection against COVID19. The AZ vaccine is a key part of the Australian COVID prevention strategy. However, we must ask ourselves whether or not the risk of adverse effects, especially clots, is acceptable in the Australian context where COVID is more or less under control. This is a vital issue to grasp if we are to make reliable recommendations to our patients. Furthermore, we must take a close look at whether or not the efficacy of the AZ vaccine is high enough for us to achieve herd immunity. As the public becomes increasingly hesitant with regard to the AZ vaccine, the likelihood of us vaccinating enough of the population to achieve herd immunity diminishes rapidly.

Last Updated: 26 May, 2021

Rate this podcast
Help your colleagues find podcasts they'll enjoy by rating this podcast out of five stars.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Spiros Fourlanos & Samantha Stuk

A/Prof Spiros Fourlanos & Samantha Stuk

Maintaining Muscle Mass & Nutritional Status While Losing Weight on GLP-1RAs

A/Prof Ralph Audehm & A/Prof Jeremy Grummet

A/Prof Ralph Audehm & A/Prof Jeremy Grummet

Prostate Cancer Screening Recommendations – Case Discussion & Q&A

Dr Alison Chiu

Dr Alison Chiu

Dry Eye – Practical Management Tips for Better Outcome

Dr Ted Wu

Dr Ted Wu

Cardiovascular Outcomes & GLP1 – An Update

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Michelle Ananda-Rajah

expert

Dr Michelle Ananda-Rajah

Infectious Diseases and General Medicine Physician; Founder, fungalAi; Co-Founder, Healthcare Workers Australia

Recent articles

Find your area of interest

Share this

You have completed the Educational Activities (EA) component of this activity.

Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.

You will be taken to explore further CPD learning available to you.

Upcoming Healthed Webcast

TONIGHT - Tuesday 30th September, 7pm - 9pm AEST

Speaker

A/Prof Spiros Fourlanos & Samantha Stuk

Director of Clinical Studies, Ballarat Clinical School at Deakin University

We invite you to our next free webcast, where A/Prof Spiros Fourlanos & Samantha Stuk discuss GLP-1RAs. Earn up to 4 hours CPD. Accredited with RACGP and ACRRM.